Acumen’s Alzheimer’s drug passes initial safety test
CHICAGO: An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals (ABOS.O) targeting a novel form of the toxic protein beta amyl…
Read more
Johnson & Johnson sues researchers who linked talc to cancer
Johnson & Johnson has sued four doctors who published studies citing links between talc-based personal care products and cancer, escalating an a…
Read more
WHO deems aspartame ‘possible cancer-causing’ ingredient
The sweetener aspartame is a “possible carcinogen” but it remains safe to consume at already-agreed levels, two groups linked to the World Health Or…
Read more
How aspartame made the agenda of the WHO’s cancer research arm
The imminent move to label aspartame as a possible carcinogen comes after years of advocacy from a leading consumer group in the United States and a…
Read more
AIDS can be ended by 2030: UN
It is possible to end AIDS by 2030 if countries demonstrate the political will to invest in prevention and treatment and adopt non-discriminatory la…
Read more
New technology developed to halt malaria-spreading mosquitoes
Malaria remains one of the world’s deadliest diseases. Each year malaria infections result in hundreds of thousands of deaths, with the majority of …
Read more
Four hospitals, several operation theatres and labs sealed
LAHORE: Four hospitals and several operation theatres and labs have been sealed by the Punjab Healthcare Commission, ARY News reported on Wednesday.…
Read more
Social Plugin